AlphaQuest LLC lessened its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 85.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 805 shares of the aerospace company's stock after selling 4,567 shares during the period. AlphaQuest LLC's holdings in Leidos were worth $116,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LDOS. Private Advisor Group LLC boosted its stake in Leidos by 83.0% during the 4th quarter. Private Advisor Group LLC now owns 8,167 shares of the aerospace company's stock valued at $1,177,000 after purchasing an additional 3,703 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in Leidos by 39.6% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,464 shares of the aerospace company's stock valued at $1,800,000 after purchasing an additional 3,534 shares during the last quarter. Fiduciary Trust Co boosted its stake in Leidos by 36.4% during the 3rd quarter. Fiduciary Trust Co now owns 23,941 shares of the aerospace company's stock valued at $3,902,000 after purchasing an additional 6,395 shares during the last quarter. LGT Fund Management Co Ltd. purchased a new stake in Leidos during the 4th quarter valued at $1,979,000. Finally, Rockefeller Capital Management L.P. purchased a new stake in Leidos during the 3rd quarter valued at $4,622,000. Institutional investors own 76.12% of the company's stock.
Insider Buying and Selling at Leidos
In other news, Director Gary Stephen May sold 2,128 shares of Leidos stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $131.24, for a total value of $279,278.72. Following the sale, the director now directly owns 11,264 shares of the company's stock, valued at approximately $1,478,287.36. The trade was a 15.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert C. Kovarik, Jr. sold 1,511 shares of Leidos stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $134.56, for a total value of $203,320.16. Following the completion of the sale, the director now directly owns 6,408 shares in the company, valued at $862,260.48. This trade represents a 19.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.96% of the company's stock.
Leidos Stock Performance
NYSE LDOS traded down $1.19 on Friday, hitting $133.66. 3,989,767 shares of the company traded hands, compared to its average volume of 1,083,413. The company has a market capitalization of $17.14 billion, a price-to-earnings ratio of 14.46, a P/E/G ratio of 1.65 and a beta of 0.72. The company has a current ratio of 1.21, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The business's 50 day moving average price is $139.37 and its 200-day moving average price is $154.31. Leidos Holdings, Inc. has a 52-week low of $123.23 and a 52-week high of $202.90.
Leidos (NYSE:LDOS - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The aerospace company reported $2.37 EPS for the quarter, beating analysts' consensus estimates of $2.24 by $0.13. Leidos had a return on equity of 30.93% and a net margin of 7.53%. Equities analysts expect that Leidos Holdings, Inc. will post 10.62 earnings per share for the current year.
Leidos Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Friday, March 14th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.60 dividend on an annualized basis and a yield of 1.20%. Leidos's dividend payout ratio is presently 17.32%.
Analyst Upgrades and Downgrades
Several analysts have commented on the company. UBS Group cut their target price on Leidos from $162.00 to $156.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 12th. StockNews.com downgraded Leidos from a "strong-buy" rating to a "buy" rating in a research note on Saturday, March 8th. TD Cowen downgraded Leidos from a "buy" rating to a "hold" rating and dropped their price target for the stock from $200.00 to $165.00 in a research note on Wednesday, January 8th. Wells Fargo & Company dropped their price target on Leidos from $197.00 to $191.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 26th. Finally, The Goldman Sachs Group downgraded Leidos from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $228.00 to $153.00 in a research note on Thursday, December 12th. Six analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Leidos currently has a consensus rating of "Moderate Buy" and an average target price of $178.07.
Check Out Our Latest Report on Leidos
Leidos Company Profile
(
Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Articles

Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report